
Biomerics, a medical device contract manufacturer, has commenced construction on a new facility in Costa Rica.
The new greenfield plant will be built adjacent to the company’s existing operations in the La Zeta Free Trade Zone in Cartago.
The 110,000ft2 facility will include extrusion, injection moulding, micro metal processing, and cleanroom assembly process.
It will feature engineering labs, quality inspection labs, controlled environment manufacturing, office space, class 7 clean rooms, packaging, and warehouse facilities.
The company’s 50,000ft2 current facility employs 175 people and is focused on extrusion, laser processing, high volume assembly, and packaging.
The expansion scheme is estimated to double its manufacturing footprint as well as the number of Costa Rican employees over the next three years.

US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataBiomerics CEO Travis Sessions said: “This expansion is in line with our vision to be the leading interventional contract manufacturer.
“Customers have requested that we build a vertically integrated operation in Costa Rica to provide cost-effective high volume manufacturing for the interventional market.”
Construction work on the new facility is expected to be completed by the fourth quarter of this year.
Biomerics Sales and Marketing director Chris Richardson said: “We are excited for the value that this expansion brings to our existing customer base in Costa Rica and interventional OEM partners around the globe.
“The thriving medical device ecosystem in Costa Rica aligns well with Biomerics’ culture and innovative core.”
In August last year, hospitality firm Hilton had commenced construction to transform the Crocodile Bay Resort, a sportfishing destination in Costa Rica.
—————————————————————————————————————–
Biomerics Groundbreaking Ceremony – February 12, 2021 – Cartago, Costa Rica – (In Photo: Left to Right) – Joel Larsen (Board Member), Anthony Amador (President, Biomerics Costa Rica), Jake Wakley (VP Quality & Regulatory). (Credit: Cision US Inc.)